Skip to content

Public FDA record

Z-0274-2022: Freelite Human Lambda Free Kit (for use on the SPAPLUS) REF LK018.S Freelite Human Lambda Free Kit (for

Recall record Z-0274-2022 for The Binding Site Group, Ltd.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0274-2022
Company in FDA record
The Binding Site Group, Ltd.
FDA record creation date
Nov 19, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer.

Source facts

Action
On 10/15/2021 (revised letter 10/25/2021), the firm sent an "Urgent Medical Device Correction" Notification to customers via email to inform them that it has identified an imprecision at top of calibration curve, where the calibration curves produced using specific lots have a higher activity than routinely expected and that there may be a decrease separation between calibrator point 5 and 6 which can be exacerbated when calibrator 6 activity reaches the optical ceiling of the analyzer and may result in an inaccurate value being reported. Customers are instructed to: Adapt the calibration curve to run as a 5-point curve with immediate effect as below 1. Stop using the 6-point calibration curve for the affected kit lots. 2. Run a 5-point calibration curve by entering values for Calibrator 1 to Calibrator 5 only as found on the Quality Control Certificate provided within the kit in ascending order on Page 1 of the Item parameters. Leave Standard 6 blank. Ensure the Auto Fill button is pressed after entering the value for Calibrator 5 on page 1. The analyser will automatically calculate and enter the revised measuring ranges on Item pages 3 and 4. 3. View Item parameter pages 3 and 4 to ensure correct value entry. 4. Before requesting calibration, view the CALIB screen and delete any existing rack position and OD information shown for STD-6 of the corresponding assay. 5. Calibration curves must only be accepted if Absorbance values increase with increasing concentration as stated in Section D.2.2 of the SPAPLUS Reference Guide (FIN012). -The expiry of the above kit lots has been reduced from 31/OCT/2022 to 30/APR/2022. Update records accordingly as the affected kit lots must not be used beyond this point. 6. Fill out and return the TSWS18 E-Back form to Technical.support@bindingsite.com or to your local The Binding Site Representative within two weeks of receiving this notification. For question/further information, contact Local Binding Site Representative or Techn
Initiated
2021-10-15
Root cause
Nonconforming Material/Component
Terminated
2025-02-04
Distribution
U.S.: CA, CO, FL, IL, IN, KY, LA, MI, NY, OK, SD, TX and VA. O.U.S.: Canada
Recall number
Z-0274-2022
Recall status
Terminated
CDRH record ID
190021
FDA record created
2021-11-19
Recall event number
88921

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗